SCHEMBL538161

SCHEMBL538161

CC(Cl)NC(C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL2064861 0.95
Hydrochloric Acid SCHEMBL538160 0.95
SCHEMBL10716303 0.82
Hydrochloric Acid SCHEMBL6508564 0.79
SCHEMBL8901756 0.76
SCHEMBL2556849 0.71
SCHEMBL7725 0.71
SCHEMBL2378433 0.70
Dimethylamine SCHEMBL9854037 0.67 ALDH1A1 (0.56)
Dimethylamine SCHEMBL7893155 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100284905-A1 Methods and Agents for Inhibiting Tumor Growth by Targeting the SSDNA Replication Intermediate of Tumor Stem Cells Massachusetts Institute of Tehnology 2010-11-11 US claimed
EP-2171448-A2 METHODS AND AGENTS FOR INHIBITING TUMOR GROWTH BY TARGETING THE SSDNA REPLICATION INTERMEDIATE OF TUMOR STEM CELLS Massachusetts Institute of Technology (US) 2010-04-07 EP claimed
WO-2008156629-A2 METHODS AND AGENTS FOR INHIBITING TUMOR GROWTH BY TARGETING THE SSDNA REPLICATION INTERMEDIATE OF TUMOR STEM CELLS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2008-12-24 WO claimed
EP-0354093-B1 Piperazine derivatives and process for their preparation SYNTHELABO (FR) 1993-12-22 EP claimed
EP-0354093-A1 Piperazine derivatives and process for their preparation SYNTHELABO (FR) 1990-02-07 EP claimed
US-20240390331-A1 ORAL BENDAMUSTINE FORMULATIONS TUBE PHARMACEUTICALS GMBH (AT) 2024-11-28 US disclosed
EP-3691637-A1 ORAL BENDAMUSTINE FORMULATIONS TUBE Pharmaceuticals GmbH (AT) 2020-08-12 EP disclosed
US-20200246312-A1 ORAL BENDAMUSTINE FORMULATIONS TUBE PHARMACEUTICALS GMBH (AT) 2020-08-06 US disclosed
CN-111201019-A Oral bendamustine formulations 图贝药物有限公司 2020-05-26 CN disclosed
WO-2019068904-A1 ORAL BENDAMUSTINE FORMULATIONS TUBE PHARMACEUTICALS GMBH (AT) 2019-04-11 WO disclosed
CN-108290910-A N, N-bis (2-dialkylphosphinoethyl) amine-borane complex, process for producing the same, and process for producing ruthenium complex using the amine as ligand 高砂香料工业株式会社 2018-07-17 CN disclosed
US-9987211-B2 Sunless tanning compounds and compositions REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2018-06-05 US disclosed
US-4734225-A ANTITUMOR AGENTS MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 1988-03-29 US disclosed
EP-0256936-A1 4-Benzyl piperazine derivatives, their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1988-02-24 EP disclosed
EP-0225608-A2 Medicine Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1987-06-16 EP disclosed
EP-0083442-B1 PROCESS FOR THE PRODUCTION OF 2,4,6-TRICHLOROANILINE BAYER AG (DE) 1986-08-20 EP disclosed
EP-0110795-B1 PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC SANTE (FR) 1986-03-12 EP disclosed
EP-0110795-A1 Pyrrolidine derivatives, their preparation and medicines containing them RHONE-POULENC SANTE (FR) 1984-06-13 EP disclosed
EP-0083442-A2 Process for the production of 2,4,6-trichloroaniline BAYER AG (DE) 1983-07-13 EP disclosed
US-4007180-A POLYESTERS HOECHST AKTIENGESELLSCHAFT (DT) 1977-02-08 US disclosed